<DOC>
	<DOCNO>NCT01417884</DOCNO>
	<brief_summary>Molecular target platelet pivotal development new pharmacological substrate platelet inhibition well understand impact platelet-mediated inflammatory process progression heart disease , coronary heart disease chronic heart failure . Previous investigation thienopyridine Clopidogrel underlined importance combine risk factor analysis . Thus , clopidogrelÂ´s prognostic efficacy relies combination genetic factor ( mainly polymorphisms CYP2C19 encode gene ) non-genetic factor , age , diabetes mellitus concomitant drug . Therefore , prospective patient cohort exact phenotypic characterisation accord standardized protocol necessary enable examination clinical relevance potential molecular target . A supplementary provision high quality bio-material enables systematic examination new promise platelet-biomarkers cardiovascular disease , already produce significant result experimental animal and/or cell biologic model . Primary objective central project establish prospective cardiological cohort set Cardiovascular Clinical Research Unit ( CCRU ) affiliate Biobank thus review clinical significance potential target derive individual subprojects within research group ( German Research Council KFO 274/1-1 ) safeguard translational approach .</brief_summary>
	<brief_title>Monocentric Registry Investigate Role Platelet Function , Platelet Pharmacogenomics , Proteomics Metabonomics Ischemic Non-ischemic Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>1 . Patients ischemic nonischemic heart disease 2. informed consent patient relatives case miss capacity consent due health status 1 . Patients &lt; 18 year 2. miss inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>molecular cardiology</keyword>
	<keyword>molecular epidemiology</keyword>
	<keyword>platelet</keyword>
	<keyword>cardiovascular disease</keyword>
</DOC>